technetium tc-99m pyrophosphate
Trade name: Technescan
Small moleculeapprovedImaging agent
Approved
May 28, 1974
Clinical trial activity
0 trials · 0 clinical orgs · 4 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Timeline
1970s
- May 28, 1974
Curium Pharma — Earliest FDA Approval
- May 28, 1974
Curium Pharma — NDA Secondary Org
- May 28, 1974
Curium Pharma — NDA Organization
- Oct 20, 1976
Bracco — NDA Secondary Org
1980s
- Jun 30, 1987
Pharmalucence — NDA Secondary Org
- Jun 30, 1987
Sun Pharmaceuticals — Marketing Organization
- Jun 30, 1987
Sun Pharmaceuticals — NDA Secondary Org
Indications
Approved for
Mechanism of action
- CalciumBINDING AGENT
Calcium binding agent
- Unspecified targetOTHER
Diagnostic agent
Approval history
- approvedMay 28, 1974
Chemistry & pharmacology
- Mol. weight
- 276.88 g/mol
- Chirality
- Achiral Molecule
- Inorganic
- Yes
- Polymer
- No
- Delivery
- Parenteral
- Availability
- Prescription Only
- Imaging
- 99-Technetium
Oral
No
Parenteral
Yes
Topical
No
Sources
- ChEMBLCHEMBL1200333 ↗
Also known as
- cis-pyro
- phosphotec
- phosphotec
- pyrophosphate kit
- technescan pyp kit
- technescan pyp kit
- technetium (99mtc) pyrophosphate
- technetium (99mtc) pyrophosphate
- technetium (99mtc) pyrophosphate
- technetium tc 99m pyrophosphate
- technetium tc 99m pyrophosphate
- technetium tc 99m pyrophosphate
- technetium tc-99m pyrophosphate
- technetium tc-99m pyrophosphate
- technetium tc-99m pyrophosphate
- technetium tc-99m pyrophosphate kit
- technetium tc-99m pyrophosphate kit
Organizations
Marketing (6)
| Organization | Org type | Relationship | Date |
|---|---|---|---|
| Bracco | For profit | NDA2 | Oct 20, 1976 |
| Curium Pharma | For profit | NDA2 | May 28, 1974 |
| Curium Pharma | For profit | NDA | May 28, 1974 |
| Pharmalucence | For profit | NDA2 | Jun 30, 1987 |
| Sun Pharmaceuticals | For profit | MKTG | Jun 30, 1987 |
| Sun Pharmaceuticals | For profit | NDA2 | Jun 30, 1987 |